In other recent news, Aclarion, Inc., a medical laboratory services provider, has executed a reverse stock split at a ratio of 1-for-335, a move aimed at maintaining compliance with Nasdaq's ...

In other recent news, Aclarion, Inc., a medical laboratory services provider, has executed a reverse stock split at a ratio of 1-for-335, a move aimed at maintaining compliance with Nasdaq's continued ...

BROOMFIELD, Colo. - Aclarion, Inc. (NASDAQ: ACON, ACONW), a healthcare technology company, announced today that it has raised nearly $20 million in gross proceeds since January 1, 2025. This funding ...

Following the reverse stock split, the company's common stock will continue to trade on the Nasdaq Capital Market under the symbol "BTAI" with the new CUSIP number, 09075P204. The reverse stock split ...

Holdings announced the date of effectiveness and the ratio of a forthcoming reverse stock split of the Company’s Common ...